Skip to content

Public FDA record

Z-1246-2025: Medtronic Pipeline Vantage Embolization Device with Shield Technology, REF: PED3-021-350-16, PED3-021-250

Recall record Z-1246-2025 for Micro Therapeutics, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1246-2025
Company in FDA record
Micro Therapeutics, Inc.
FDA classification date
Mar 5, 2025
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

Use of embolization device with diameters greater-than-or-equal-to 4mm may lead to incomplete wall apposition and/or braid deformation (fish-mouthing/braid narrowing/braid collapse) noted during procedure and post-procedure, typically noted at 6-12 month imaging follow-up, potentially can lead to thrombosis and/or serious adverse events. Higher risk in females less-than-or-equal-to 45 years of age

Source facts

Action
On 1/30/2025, Medtronic Neurovascular mailed "Urgent Safety and Labeling Notification" recall notices to healthcare professions who were asked to do the following: Removal (retrieval) is isolated to unused inventory of the Pipeline Vantage 027 devices: 1) Remove and quarantine all unused impacted products in your inventory. 2) Return the impacted products to firm. Firm representative can assist with identifying suitable replacement product. Correction of Instructions for Use applies to Pipeline Vantage 021 devices: The key updates are: 1) Appropriate device diameter and length selection to account for complex anatomy. 2) Techniques to deploy Pipeline Vantage compared to Pipeline Shield using a balance of device tension and compression to achieve adequate wall apposition and landing around curves. 2) Warnings about the consequences of incomplete wall apposition and suboptimal deployment and the increased risk of braid deformation in females, especially in females less-than-or-equal-to 45 years of age. Updated IFU M067713CDOC2 Rev. A (01/2025) was sent with the notice and can be found at: https://manuals.medtronic.com/manuals/ Share this communication within your organization, with other organizations where impacted devices have been transferred, and any other associated organizations that may be impacted by this action. Please maintain a copy of this letter for your records and the records of your patients. Complete and return the customer confirmation form via email to neuro.quality@medtronic.com Questions can be directed to the firm at rs.nvquality@medtronic.com or call at 1(800) 633-8766 (US Toll free) or (763) 514-4000 (Worldwide), available 24 hours a day, 7 days a week.
Initiated
2025-01-30
Root cause
Device Design
Distribution
Worldwide distribution: US (nationwide): PR, OK, CA, MD, FL, NY, WA, MI, AL, NV, MN, NJ, IL, OH, AK, CT, TN, MO, TX, ID, AZ, WI, PA, OR, SD, VA, CO, GA, KY, IN, AR, MA, LA, NE, MT, ME, SC, DC, NC, ND, NM, IA, UT, KS, WV, NH, HI, RI. And OUS (foreign) countries of: Algeria, Argentina, Armenia, Australia, Austria, Bahrain, Bangladesh, Belgium, Brazil, Bulgaria, Canada, Canary Islands, Chile, Colombia, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon, Lithuania, Luxembourg, Malaysia, Martinique, Mexico, Republic Of Moldova, Montenegro, Morocco, Netherlands, New Zealand, North Macedonia, Northern Ireland, Norway, Panama, Peru, Philippines, Poland, Portugal, Qatar, Reunion, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Tunisia, Turkey, Ukraine, United Arab Emirates, United Kingdom, Uruguay, Vietnam
Recall number
Z-1246-2025
Recall status
Open, Classified
CDRH record ID
212391
FDA classified
2025-03-05
Recall event number
96168

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗